The shot will likely be exorbitant in the USA. Gilead charged almost $2k/month for Truvada (list price, of course) and Descovy is the same. Generic Truvada is like $30/month now, so the price was never about the cost to manufacture. Obviously Gilead is developing these new drugs/shots for when Descovy's patent expires.
They rely on the government mandating that health insurance companies cover the shots. This drives up the price.
They rely on the government mandating that health insurance companies cover the shots. This drives up the price.